Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

New insights on a major protein involved in Alzheimer’s disease

Published on: 16/12/2020 Reading time: 1 min
image
Retour à la recherche

New study conducted by Irini Kessissoglou in the “Brain development” team headed by Bassem Hassan at Paris Brain Institute reveals new functions for the Amyloid Precursor Protein (APP) homologue in drosophila. Results are published in PLOS Biology.

The amyloid precursor protein (APP) is an essential protein, best known for its involvement in the pathway at the origin of amyloid beta, the component of the main lesion in Alzheimer’s disease (AD), the amyloid plaques. Mutations in the APP gene are linked with early-onset familial cases of AD. However, the physiological role of APP in adult brain function and whether there is any link between this normal role and defects seen in AD remains unclear. To address this issue, Kessissoglou et al. investigated the function of this protein in the fruit fly, Drosophila melanogaster, a model organism often used in biomedical research which possesses a homologue of APP, called APPL (Amyloid precursor protein like).

Neurons, like all cells, possess a system called the endolysosomal recycling and degradation pathway for separating, recycling and, when necessary, trashing its proteins. This system guarantees protein and organelles balance neurons and it has been shown to be defective in human neurons with AD patient mutations, suggesting that APP may be be important for this process under normal conditions.

Using Drosophila model of APPL loss of function, the authors explored the molecular and cellular mechanisms underlying the brain homeostasis, which can be defined as the physiological processes necessary to maintain brain health and restoring balance in case of injury or diseases.

They identified a pathway crucial for adult brain homeostasis involving APPL. Indeed, APPL loss of function leads in a disruption of the endolysosomal function in neurons followed by cell death. The dead neuronal cell, which are significantly increased with the loss of APPL, accumulate in the brain at early age. Moreover, not only did flies lacking APPL have a shorter lifespan and neurodegeneration by 30 days old (a middle-old age at the scale of a Drosophila), their brain also showed signs of dysfunctional homeostasis as early as 7 days old.

One key point of the study is the evidence that the extracellular domain of APPL secreted by neurons interacts with glial cells to regulate their endolysosomal pathway and enable the clearance of neuronal debris. Glial cells are key elements of brain homeostasis as they are involved in immune response, providing nutrients to neurons and clearance of cellular wastes. Overall, this suggest that APPL is part of a neuro-glial signaling system responsible for monitoring brain health.

The results of this study bring new insights on the role of APP in a physiological context and highlight its importance for adult brain homeostasis. The findings regarding the consequences of the loss of APP suggests a strong link between its physiological functions and the defects observed in familial cases of Alzheimer’s disease. The early effects observed in flies lacking APPL support the idea of long-term modifications in the brain occurring before the onset of clinical symptoms, fostering new research on early endosomes and neuro-glial interactions in this disease.

Sources

https://pubmed.ncbi.nlm.nih.gov/33290404/
Kessissoglou IA, Langui D, Hasan A, Maral M, Dutta SB, Hiesinger PR, Hassan BA.PLoS Biol. 2020 Dec 8

Our news on the subject

Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
See all our news